These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 18390465)
61. Emergency: Bioterrorism. Hagstad D Am J Nurs; 2000 Dec; 100(12):33-5. PubMed ID: 11202782 [No Abstract] [Full Text] [Related]
62. The threat of biological terrorism: a public health and infection control reality. Leggiadro RJ Infect Control Hosp Epidemiol; 2000 Jan; 21(1):53-6. PubMed ID: 10656359 [TBL] [Abstract][Full Text] [Related]
63. Current therapy and the development of therapeutic options for the treatment of diseases due to bacterial agents of potential biowarfare and bioterrorism. Greenfield RA; Bronze MS Curr Opin Investig Drugs; 2004 Feb; 5(2):135-40. PubMed ID: 15043386 [TBL] [Abstract][Full Text] [Related]
64. Biological agents of bioterrorism - preparedness is vital. Janoutová J; Filipčíková R; Bílek K; Janout V Epidemiol Mikrobiol Imunol; 2020; 69(1):42-47. PubMed ID: 32326715 [TBL] [Abstract][Full Text] [Related]
66. Current and future medical approaches to combat the anthrax threat. Bouzianas DG J Med Chem; 2010 Jun; 53(11):4305-31. PubMed ID: 20102155 [No Abstract] [Full Text] [Related]
67. Current concepts in the management of biologic and chemical warfare causalities. Joseph B; Brown CV; Diven C; Bui E; Aziz H; Rhee P J Trauma Acute Care Surg; 2013 Oct; 75(4):582-9. PubMed ID: 24064869 [No Abstract] [Full Text] [Related]
70. Agents of bioterrorism. Preparing for bioterrorism at the community health care level. Miller JM Infect Dis Clin North Am; 2001 Dec; 15(4):1127-56. PubMed ID: 11780270 [TBL] [Abstract][Full Text] [Related]
71. Pulmonary manifestations of other agents: brucella, Q fever, tularemia and smallpox. Wortmann G Respir Care Clin N Am; 2004 Mar; 10(1):99-109. PubMed ID: 15062230 [TBL] [Abstract][Full Text] [Related]
72. Missed sentinel case of naturally occurring pneumonic tularemia outbreak: lessons for detection of bioterrorism. Dembek ZF; Buckman RL; Fowler SK; Hadler JL J Am Board Fam Pract; 2003; 16(4):339-42. PubMed ID: 12949036 [TBL] [Abstract][Full Text] [Related]
73. Plants as biofactories for the production of subunit vaccines against bio-security-related bacteria and viruses. Rigano MM; Manna C; Giulini A; Vitale A; Cardi T Vaccine; 2009 May; 27(25-26):3463-6. PubMed ID: 19460602 [TBL] [Abstract][Full Text] [Related]
74. Biological and chemical agents: a brief synopsis. Rosenbloom M; Leikin JB; Vogel SN; Chaudry ZA Am J Ther; 2002; 9(1):5-14. PubMed ID: 11782813 [TBL] [Abstract][Full Text] [Related]
75. Bichat guidelines for the clinical management of tularaemia and bioterrorism-related tularaemia. Bossi P; Tegnell A; Baka A; Van Loock F; Hendriks J; Werner A; Maidhof H; Gouvras G; Euro Surveill; 2004 Dec; 9(12):E9-10. PubMed ID: 15677845 [TBL] [Abstract][Full Text] [Related]
76. Botulinum toxin. Horowitz BZ Crit Care Clin; 2005 Oct; 21(4):825-39, viii. PubMed ID: 16168317 [TBL] [Abstract][Full Text] [Related]
77. [Detection and identification of a biological attack]. Orr-Urtreger A; Katz LH; Brenner B Harefuah; 2002 May; 141 Spec No():29-30, 122. PubMed ID: 12170550 [TBL] [Abstract][Full Text] [Related]
78. Management of patients exposed to biologic weapons. Yetman RJ; Parks D; Taft E J Pediatr Health Care; 2002; 16(5):256-61. PubMed ID: 12226595 [No Abstract] [Full Text] [Related]
79. Mucormycosis: a rare but serious infection. Eichna DM; Brown KS; Breen A; Dean RB Clin J Oncol Nurs; 2008 Feb; 12(1):108-12. PubMed ID: 18258580 [TBL] [Abstract][Full Text] [Related]
80. Particulate delivery systems for biodefense subunit vaccines. Bramwell VW; Eyles JE; Oya Alpar H Adv Drug Deliv Rev; 2005 Jun; 57(9):1247-65. PubMed ID: 15935873 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]